Artificial Intelligence

Zoetis is acquiring Neogen's genomics unit for $160M, a strategic move set to accelerate data-driven innovation in livestock and companion animal care.

Asia's largest pharma show returns, showcasing China's evolution from the world's factory to a global hub of drug innovation and supply chain strategy.

With a strong cash position and promising drug candidate, Apogee Therapeutics is advancing multiple trials to challenge the I&I market with a new therapy.

Amid soaring cyber-attack costs in Asia, cloud security firm Upwind is tripling its workforce and deploying local infrastructure to deliver real-time protection.

The healthcare firm reports a 56% revenue surge to $3.2B, but a "material weakness" in financial controls and a delayed SEC filing cast a shadow.

At MODEX 2026, KNAPP will unveil its AI-driven 'Brain' and award-winning 3D robots, promising a new era of intelligent, adaptive supply chains.

Lynk Pharmaceuticals reports its oral drug zemprocitinib met all goals in a late-stage study for atopic dermatitis, offering rapid itch relief and a strong safety profile.

As MSA Awareness Month begins, a novel drug from Alterity Therapeutics shows significant promise in slowing the devastating and untreatable neurodegenerative disease.

With a strong cash runway and pivotal trials underway, Sionna Therapeutics aims to revolutionize CF treatment with a novel class of NBD1 stabilizer drugs.

As childhood nearsightedness soars, a new contact lens offers hope by not just correcting vision but actively slowing its progression in key global markets.

Huawei launches a full suite of AI, IoT, and AR solutions at EuroShop 2026, challenging tech giants and aiming to digitize every part of the retail journey.

Qubic has released Neuraxon 2.0, a bio-inspired framework using trinary logic to create 'LiveAIs' that adapt in real time, challenging static 'DeadLLMs'.

As AI-driven fraud skyrockets, the Canadian Bankers Association is arming citizens with new resources to spot scams and protect their finances.

With a new CTO and data from 6.6M patients, SBC Medical is building an AI-driven empire. But will this tech leap enhance care or displace workers?

Hopes for a new Huntington's gene therapy face a major delay as the FDA rejects uniQure's current data and calls for a more rigorous, complex study.

Epson unveils a suite of printers, scanners, and projectors at HIMSS 2026, aiming to reduce errors, streamline workflows, and boost patient safety.

Argo Biopharma's new CFO/CSO, Dr. Gena Wang, leaves a star analyst career at Barclays, signaling a major validation for the company's siRNA platform.

RIB Software's virtual event will gather global experts to explore how AI and connected data are tackling fragmentation and reshaping the AEC industry.

AI firm MiniMax reports a 159% revenue surge alongside a massive paper loss, revealing the strange economics of AI growth and its global ambitions.

With star-studded advisory board, a new biotech firm aims to turn routine dental visits into a frontline defense against oral cancer.